Cefempidone

This classification denotes a cephalosporin antibiotic with the molecular formula C22H21N7O6S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3YUZ4494BQ, chemically known as 1-(((6r,7r)-7-(2-(2-amino-5-thiazolyl)glyoxylamido)-2-carboxy-8-oxo-5-thia-1-azacicyclo(4.2.0)oct-2-en-3-yl)methyl)pyridinium hydroxide, inner salt, 7,2-(e)-(o-(2-oxo-3-pyrrolidinyl)oxime). but more generally known as cefempidone, which bears US NIH Compound Identifier 9578269. European Medicines Agency schedules Cefempidone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07389MIG. The term CEFEMPIDONE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 1, No. 4, 1987, List 27). CEFEMPIDONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule cefempidone under HS 29419000 and SITC 54139. As of Q4 2014, CEFEMPIDONE remains the US FDA Preferred Term for this commodity. Cefempidone bears US NLM identifiers UMLS ID C2699137 and NCI Concept Code C76163. SMILES: S1C2N(C(=O)C2NC(=O)/C(=N/OC2CCNC2=O)C2SC(NC2)N)C(=C(C1)C[N]1CCCCC1)C(=O)O.